Exact Sciences Corporation - Common Stock (NQ:EXAS)

Which of these rebounding biotech stocks is the better buy right now?

Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?

February 16, 2023

Are these stocks still good buys right now?

The Latest Analyst Ratings for Exact Sciences

February 10, 2023

Via Benzinga

3 Growth Stocks That Are Off to Hot Starts in 2023

February 08, 2023

Looking to profit off the current AI boom? Here are the most important AI penny stocks for investors to be watching.

7 AI Penny Stocks to Watch as a New Bull Market Emerges

February 07, 2023

The stock is full of potential -- and risk.

Could Exact Sciences Stock Help You Become a Millionaire?

February 03, 2023

Moving forward, this company could perform much better than it did last year.

1 Soaring Growth Stock to Buy and Hold for 10 Years

February 02, 2023

Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.

Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023

February 10, 2023

Via Benzinga

Is Biotech Immunocore About To Make A 25% Price Move?

February 07, 2023

The company's fast-growing business has loads of potential, but it may not be suitable for all investors.

Topics ETFs

Will Investors Notice Exciting Sign On Exact Sciences's Chart?

January 12, 2023

Via Benzinga

Is Exact Sciences a Buy?

January 12, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?

February 05, 2023

Via Talk Markets

Five Best And Worst Performing Healthcare Stocks In January 2023

February 05, 2023

After a sub-par performance in 2021, healthcare stocks outperformed the S&P 500 in 2022. As well, 2023 is expected to be another promising year for the sector. Let’s take a look at the five best and...

Via Talk Markets

Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?

February 02, 2023

Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023?

Biophytis (BPTS) stock is taking off on Thursday after the company released positive results from a Phase 2/3 clinical trial.

Topics ETFs

Why Is Biophytis (BPTS) Stock Up 69% Today?

February 02, 2023

Cathie Wood thinks Exact Sciences can ride the AI boom to the top. Here's what investors need to know about EXAS stock.

Cathie Wood Is Doubling Down on This Hidden-Gem Artificial Intelligence Stock

February 02, 2023

Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company

January 31, 2023

Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at

Via Benzinga

'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month

January 25, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec.

Via Benzinga

Better Long-Term Buy in 2023: Exact Sciences or Veracyte?

January 24, 2023

As cancer screenings are becoming covered more often, both companies stand to gain.

Wood's ARK Innovation ETF is rebounding nicely.

Cathie Wood Is Trouncing the Market So Far in 2023 Mainly Due to These 3 Stocks

January 24, 2023

The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year.

Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023

January 23, 2023

Via Benzinga

48.8% of Cathie Wood's Portfolio Is in These 7 Stocks

January 23, 2023

Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.

Down 40% in 2022, Can Exact Sciences Recover in 2023?

January 23, 2023

Cathie Wood is known for her deep understanding of tech companies and for holding aggressive long positions in her tech funds. Let's look at what she's buying.

Cathie Wood Is Buying These Stocks, Should You?

January 18, 2023

Bulls And Bears Of The Week: Tesla, Apple, Microsoft And Dogecoin Millionaire's Plan To Buy More Cardano

Topics ETFs

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023

January 18, 2023

Via Benzinga

January 14, 2023

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

The Stocks Behind 2022's Popular ETFs

January 12, 2023

One of the most popular actively managed ETFs in 2022 for inflows was the JPMorgan Equity Premium Income ETF (JEPI). It holds 125 stocks and is currently paying a 12-month yield of 9.64%.

Via Talk Markets

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla

January 11, 2023

Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week.

Via Benzinga

Exact Sciences Corp Stock Price Is Trending Up Here's Why

January 10, 2023

Exact Science's stock price is shooting higher this week amid posting upward revisions for its revenue and earnings estimates for this quarter.